Timing of Rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis
Rheumatology (Oxford)
.
2021 Feb 20;keab175.
doi: 10.1093/rheumatology/keab175.
Online ahead of print.
Authors
Luca Quartuccio
1
,
Elena Treppo
1
,
Marco Binutti
1
,
Giulia Del Frate
1
,
Salvatore De Vita
Affiliation
1
Rheumatology Clinic ASUFC, Department of Medicine (DAME), University of Udine, Udine, Italy.
PMID:
33609106
DOI:
10.1093/rheumatology/keab175
No abstract available